Citations (102)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Katrina Wilcox Hagberg, Annelies L Robijn & Susan Jick. (2018) Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring. Clinical Epidemiology 10, pages 1599-1612.
Read now
Read now
Beth Smith & Steven L. Dubovsky. (2017) Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women. Expert Opinion on Pharmacotherapy 18:16, pages 1703-1719.
Read now
Read now
Lars Henning Pedersen. (2017) The risks associated with prenatal antidepressant exposure: time for a precision medicine approach. Expert Opinion on Drug Safety 16:8, pages 915-921.
Read now
Read now
Faruk Uguz. (2016) A pharmacological approach to panic disorder during pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine 29:9, pages 1468-1475.
Read now
Read now
Articles from other publishers (98)
Anna L. Arzuaga, Daisy D. Edmison, Jessica Mroczek, John Larson & Michael E. Ragozzino. (2023) Prenatal stress and fluoxetine exposure in mice differentially affect repetitive behaviors and synaptic plasticity in adult male and female offspring. Behavioural Brain Research 436, pages 114114.
Crossref
Crossref
Frank M. C. Besag & Michael J. Vasey. (2022) Should Antidepressants be Avoided in Pregnancy?. Drug Safety 46:1, pages 1-17.
Crossref
Crossref
Anouschka S. Ramsteijn, Rikst Nynke Verkaik-Schakel, Danielle J. Houwing, Torsten Plösch & Jocelien D. A. Olivier. (2022) Perinatal exposure to fluoxetine and maternal adversity affect myelin-related gene expression and epigenetic regulation in the corticolimbic circuit of juvenile rats. Neuropsychopharmacology 47:9, pages 1620-1632.
Crossref
Crossref
Bianca Danciu, Horaţiu Alexandru Moisa, Dora Boghiţoiu, Ana Maria Alexandra Stănescu & Anca A. Simionescu. (2022) To treat or not to treat depression during pregnancy? A therapeutic challenge. Psihiatru.ro 1:68, pages 16.
Crossref
Crossref
Melanie P. Leussis, Jessica M. Thanos, Alex Powers, Emalee Peterson, Joshua P. Head, Nathan J. McGovern, Francis J. Malarkey & Anna Drake. (2021) Sex differences in long-term behavioral alterations, especially anxiety, following prenatal fluoxetine exposure in C57BL/6 mice. Pharmacology Biochemistry and Behavior 211, pages 173293.
Crossref
Crossref
Jakob Christensen, Betina B. Trabjerg, Yuelian Sun & Julie Werenberg Dreier. (2021) Association of Maternal Antidepressant Prescription During Pregnancy With Standardized Test Scores of Danish School-aged Children. JAMA 326:17, pages 1725.
Crossref
Crossref
Torkel Carlsson, Felix Molander, Mark J. Taylor, Ulf Jonsson & Sven Bölte. (2020) Early environmental risk factors for neurodevelopmental disorders – a systematic review of twin and sibling studies. Development and Psychopathology 33:4, pages 1448-1495.
Crossref
Crossref
Genevieve Grivas, Richard Frye & Juergen Hahn. (2021) Pregnant Mothers’ Medical Claims and Associated Risk of Their Children being Diagnosed with Autism Spectrum Disorder. Journal of Personalized Medicine 11:10, pages 950.
Crossref
Crossref
Jennifer L. Ames, Christine Ladd-Acosta, M. Daniele Fallin, Yinge Qian, Laura A. Schieve, Carolyn DiGuiseppi, Li-Ching Lee, Eric P. Kasten, Guoli Zhou, Jennifer Pinto-Martin, Ellen M. Howerton, Christopher L. Eaton & Lisa A. Croen. (2021) Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders. Biological Psychiatry 90:4, pages 253-262.
Crossref
Crossref
Karine Liu, Alfonso Garcia, Jenn J. Park, Alexis A. Toliver, Lizmaylin Ramos & Carlos D. Aizenman. (2021) Early Developmental Exposure to Fluoxetine and Citalopram Results in Different Neurodevelopmental Outcomes. Neuroscience 467, pages 110-121.
Crossref
Crossref
Noortje Van der Knaap, Dirk Wiedermann, Dirk Schubert, Mathias Hoehn & Judith R. Homberg. (2021) Perinatal SSRI exposure affects brain functional activity associated with whisker stimulation in adolescent and adult rats. Scientific Reports 11:1.
Crossref
Crossref
Naama Rotem-Kohavi, Sherryl H. Goodman, Ashley Wazana & Tim F. Oberlander. 2021. Prenatal Stress and Child Development. Prenatal Stress and Child Development
565
593
.
Ori Kapra, Ran Rotem & Raz Gross. (2020) The Association Between Prenatal Exposure to Antidepressants and Autism: Some Research and Public Health Aspects. Frontiers in Psychiatry 11.
Crossref
Crossref
Michal Levy, Michal Kovo, Hadas Miremberg, Noa Anchel, Hadas Ganer Herman, Jacob Bar, Letizia Schreiber & Eran Weiner. (2020) Maternal use of selective serotonin reuptake inhibitors (SSRI) during pregnancy—neonatal outcomes in correlation with placental histopathology. Journal of Perinatology 40:7, pages 1017-1024.
Crossref
Crossref
A.S. Ramsteijn, L. Van de Wijer, J. Rando, J. van Luijk, J.R. Homberg & J.D.A. Olivier. (2020) Perinatal selective serotonin reuptake inhibitor exposure and behavioral outcomes: A systematic review and meta-analyses of animal studies. Neuroscience & Biobehavioral Reviews 114, pages 53-69.
Crossref
Crossref
Lin Li, Ayesha C. Sujan, Agnieszka Butwicka, Zheng Chang, Samuele Cortese, Patrick Quinn, Alexander Viktorin, A. Sara Öberg, Brian M. D’Onofrio & Henrik Larsson. (2020) Associations of Prescribed ADHD Medication in Pregnancy with Pregnancy-Related and Offspring Outcomes: A Systematic Review. CNS Drugs 34:7, pages 731-747.
Crossref
Crossref
Monica L. VegaGraham C. NewportDurim BozhdarajSamantha B. SaltzCharles B. NemeroffD. Jeffrey Newport. (2020) Implementation of Advanced Methods for Reproductive Pharmacovigilance in Autism: A Meta-Analysis of the Effects of Prenatal Antidepressant Exposure. American Journal of Psychiatry 177:6, pages 506-517.
Crossref
Crossref
Gabrielle A. Mesches, Katherine L. Wisner & Hannah K. Betcher. (2020) A common clinical conundrum: Antidepressant treatment of depression in pregnant women. Seminars in Perinatology 44:3, pages 151229.
Crossref
Crossref
Erica L. Smearman, Cassandra L. Hendrix, Dominika A. Winiarski, Katrina C. Johnson, Alicia K. Smith, Opal Y. Ousley, Zachary N. Stowe, D. Jeffrey Newport & Patricia A. Brennan. (2019) School-age social behavior and pragmatic language ability in children with prenatal serotonin reuptake inhibitor exposure. Development and Psychopathology 32:1, pages 21-30.
Crossref
Crossref
Jessica Salvador Areias de Araujo, Isabella Fernandes Delgado & Francisco José Roma Paumgartten. (2020) Antenatal exposure to antidepressant drugs and the risk of neurodevelopmental and psychiatric disorders: a systematic review. Cadernos de Saúde Pública 36:2.
Crossref
Crossref
C.M. Bond, J.C. Johnson, V. Chaudhary, E.M. McCarthy, M.L. McWhorter & N.S. Woehrle. (2020) Perinatal fluoxetine exposure results in social deficits and reduced monoamine oxidase gene expression in mice. Brain Research 1727, pages 146282.
Crossref
Crossref
Qiuying Zhao & Alexandre Bonnin. 2020. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
437
447
.
Kholoud N. Bastaki, Sura Alwan & Farah R. Zahir. 2020. Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management. Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management
143
162
.
Madoka Yamamoto-Sasaki, Satomi Yoshida, Masato Takeuchi, Sachiko Tanaka-Mizuno, Yusuke Ogawa, Toshiaki A. Furukawa & Koji Kawakami. (2019) Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data. Maternal Health, Neonatology and Perinatology 5:1.
Crossref
Crossref
Michael B Bracken. (2019) SSRIs and autism: interpreting an umbrella review. The Lancet Psychiatry 6:11, pages 893.
Crossref
Crossref
Yuelian Sun, Lars Henning Pedersen, Chun Sen Wu, Irene Petersen, Henrik Toft Sørensen & Jørn Olsen. (2019) Antidepressant use during pregnancy and risk of congenital heart defects: A case‐time‐control study. Pharmacoepidemiology and Drug Safety 28:9, pages 1180-1193.
Crossref
Crossref
Juan C. Velasquez, Qiuying Zhao, Yen Chan, Ligia C.M. Galindo, Christelle Simasotchi, Dan Wu, Zhipeng Hou, Skyla M. Herod, Tim F. Oberlander, Sophie Gil, Thierry Fournier, Irina Burd, Anne M. Andrews & Alexandre Bonnin. (2019)
In Utero
Exposure to Citalopram Mitigates Maternal Stress Effects on Fetal Brain Development
. ACS Chemical Neuroscience 10:7, pages 3307-3317.
Crossref
Crossref
Sarah Hjorth, Rebecca Bromley, Eivind Ystrom, Angela Lupattelli, Olav Spigset & Hedvig Nordeng. (2019) Use and validity of child neurodevelopment outcome measures in studies on prenatal exposure to psychotropic and analgesic medications – A systematic review. PLOS ONE 14:7, pages e0219778.
Crossref
Crossref
A. Halvorsen, B. Hesel, S. D. Østergaard & A. A. Danielsen. (2019)
In utero
exposure to selective serotonin reuptake inhibitors and development of mental disorders: a systematic review and meta‐analysis
. Acta Psychiatrica Scandinavica 139:6, pages 493-507.
Crossref
Crossref
Edwin R. Raffi, Ruta Nonacs & Lee S. Cohen. (2019) Safety of Psychotropic Medications During Pregnancy. Clinics in Perinatology 46:2, pages 215-234.
Crossref
Crossref
Asher Ornoy & Gideon Koren. (2019) SSRIs and SNRIs (SRI) in Pregnancy: Effects on the Course of Pregnancy and the Offspring: How Far Are We from Having All the Answers?. International Journal of Molecular Sciences 20:10, pages 2370.
Crossref
Crossref
Ayesha C. Sujan, A. Sara Öberg, Patrick D. Quinn & Brian M. D'Onofrio. (2018) Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems – a critical review and recommendations for future research. Journal of Child Psychology and Psychiatry 60:4, pages 356-376.
Crossref
Crossref
Getinet Ayano, Joemer Calderon Maravilla & Rosa Alati. (2019) Risk of autistic spectrum disorder in offspring with parental mood disorders: A systematic review and meta-analysis. Journal of Affective Disorders 248, pages 185-197.
Crossref
Crossref
Zixuan Wang, Phoebe W. H. Ho, Michael T. H. Choy, Ian C. K. Wong, Ruth Brauer & Kenneth K. C. Man. (2018) Advances in Epidemiological Methods and Utilisation of Large Databases: A Methodological Review of Observational Studies on Central Nervous System Drug Use in Pregnancy and Central Nervous System Outcomes in Children. Drug Safety 42:4, pages 499-513.
Crossref
Crossref
Jianjun Ou, Ruiting Liu, Yidong Shen, Kun Xia & Jingping Zhao. (2019) An Overview of Genetic and Environmental Risk of Autism Spectrum Disorder. Global Clinical and Translational Research, pages 37-44.
Crossref
Crossref
Leonardo Emberti Gialloreti, Luigi Mazzone, Arianna Benvenuto, Alessio Fasano, Alicia Garcia Alcon, Aletta Kraneveld, Romina Moavero, Raanan Raz, Maria Pia Riccio, Martina Siracusano, Ditza A. Zachor, Marina Marini & Paolo Curatolo. (2019) Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations. Journal of Clinical Medicine 8:2, pages 217.
Crossref
Crossref
Valentina R. Garbarino, T. Lee Gilman, Lynette C. Daws & Georgianna G. Gould. (2019) Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder. Pharmacological Research 140, pages 85-99.
Crossref
Crossref
Sophie Grigoriadis & Miki Peer. 2019. Perinatal Psychopharmacology. Perinatal Psychopharmacology
69
98
.
Sura Alwan & Anick Bérard. 2019. Perinatal Psychopharmacology. Perinatal Psychopharmacology
3
16
.
Kara Brown & Dylan Kathol. 2019. Neurology and Psychiatry of Women. Neurology and Psychiatry of Women
157
172
.
Xi-Hong Zhou, Yong-Jiang Li, Jian-Jun Ou & Ya-Min Li. (2018) Association between maternal antidepressant use during pregnancy and autism spectrum disorder: an updated meta-analysis. Molecular Autism 9:1.
Crossref
Crossref
Daniel R. Morales, Jim Slattery, Stephen Evans & Xavier Kurz. (2018) Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations. BMC Medicine 16:1.
Crossref
Crossref
Samata R. Sharma, Xenia Gonda & Frank I. Tarazi. (2018) Autism Spectrum Disorder: Classification, diagnosis and therapy. Pharmacology & Therapeutics 190, pages 91-104.
Crossref
Crossref
Katie R. Thorsness, Corey Watson & Elizabeth M. LaRusso. (2018) Perinatal anxiety: approach to diagnosis and management in the obstetric setting. American Journal of Obstetrics and Gynecology 219:4, pages 326-345.
Crossref
Crossref
Elizabeth Hisle-Gorman, Apryl Susi, Theophil Stokes, Gregory Gorman, Christine Erdie-Lalena & Cade M Nylund. (2018) Prenatal, perinatal, and neonatal risk factors of autism spectrum disorder. Pediatric Research 84:2, pages 190-198.
Crossref
Crossref
Susanne Brummelte. (2018) Treating Maternal Depression: Considerations for the Well-Being of the Mother and Child. Policy Insights from the Behavioral and Brain Sciences 5:1, pages 110-117.
Crossref
Crossref
Yusuf Cem Kaplan, Elif Keskin‐Arslan, Selin Acar & Kaan Sozmen. (2017) Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta‐analysis of cohort studies. British Journal of Clinical Pharmacology 83:12, pages 2798-2806.
Crossref
Crossref
A. Viktorin, R. Uher, A. Reichenberg, S. Z. Levine & S. Sandin. (2017) Autism risk following antidepressant medication during pregnancy. Psychological Medicine 47:16, pages 2787-2796.
Crossref
Crossref
Sean Ackerman, Sarah Schoenbrun, Caitlin Hudac & Raphael Bernier. (2017) Interactive Effects of Prenatal Antidepressant Exposure and Likely Gene Disrupting Mutations on the Severity of Autism Spectrum Disorder. Journal of Autism and Developmental Disorders 47:11, pages 3489-3496.
Crossref
Crossref
Asher Ornoy. (2017) Neurobehavioral risks of SSRIs in pregnancy: Comparing human and animal data. Reproductive Toxicology 72, pages 191-200.
Crossref
Crossref
Samuel J. Millard, Katrina Weston-Green & Kelly A. Newell. (2017) The effects of maternal antidepressant use on offspring behaviour and brain development: Implications for risk of neurodevelopmental disorders. Neuroscience & Biobehavioral Reviews 80, pages 743-765.
Crossref
Crossref
J. Li & J. Chen. (2020) Comment on “Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review”. European Psychiatry 45, pages 220-220.
Crossref
Crossref
S. Andalib, M.R. Emamhadi, S. Yousefzadeh-Chabok, S.K. Shakouri, P.F. Høilund-Carlsen, M.S. Vafaee & T.M. Michel. (2020) Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review. European Psychiatry 45, pages 161-166.
Crossref
Crossref
Jay A. Gingrich, Heli Malm, Mark S. Ansorge, Alan Brown, Andre Sourander, Deepika Suri, Cátia M. Teixeira, Martha K. Caffrey Cagliostro, Darshini Mahadevia & Myrna M. Weissman. (2017) New Insights into How Serotonin Selective Reuptake Inhibitors Shape the Developing Brain. Birth Defects Research 109:12, pages 924-932.
Crossref
Crossref
Naama Rotem-Kohavi & Tim F. Oberlander. (2017) Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure. Birth Defects Research 109:12, pages 909-923.
Crossref
Crossref
Cara Angelotta & Katherine L. Wisner. (2017) Treating Depression during Pregnancy: Are We Asking the Right Questions?. Birth Defects Research 109:12, pages 879-887.
Crossref
Crossref
Hanan El Marroun, Tonya J White, Guillen Fernandez, Vincent WV Jaddoe, Frank C Verhulst, Bruno H Stricker & Henning Tiemeier. (2016) Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood. Journal of Psychopharmacology 31:3, pages 346-355.
Crossref
Crossref
Samantha K. Podrebarac, Emma G. Duerden, Vann Chau, Ruth E. Grunau, Anne Synnes, Tim F. Oberlander & Steven P. Miller. (2017) Antenatal exposure to antidepressants is associated with altered brain development in very preterm-born neonates. Neuroscience 342, pages 252-262.
Crossref
Crossref
S. Brummelte, E. Mc Glanaghy, A. Bonnin & T.F. Oberlander. (2017) Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation. Neuroscience 342, pages 212-231.
Crossref
Crossref
Thalia Robakis, Eugenia Jernick & Katherine Williams. (2017) Recent advances in understanding maternal perinatal mood disorders. F1000Research 6, pages 916.
Crossref
Crossref
Christof Schaefer, Valenka Dorsch & Anke Rohde. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
2829
2847
.
Anne-Cathrine F. Viuff, Lars Henning Pedersen, Kasper Kyng, Nicklas Heine Staunstrup, Anders Børglum & Tine Brink Henriksen. (2016) Antidepressant medication during pregnancy and epigenetic changes in umbilical cord blood: a systematic review. Clinical Epigenetics 8:1.
Crossref
Crossref
Yusuf C. Kaplan, Elif Keskin-Arslan, Selin Acar & Kaan Sozmen. (2016) Prenatal selective serotonin reuptake inhibitor use and the risk of autism spectrum disorder in children: A systematic review and meta-analysis. Reproductive Toxicology 66, pages 31-43.
Crossref
Crossref
Leah C. Susser, Stephanie A. Sansone & Alison D. Hermann. (2016) Selective serotonin reuptake inhibitors for depression in pregnancy. American Journal of Obstetrics and Gynecology 215:6, pages 722-730.
Crossref
Crossref
LE Grzeskowiak, JL Morrison, TB Henriksen, BH Bech, C Obel, J Olsen & LH Pedersen. (2016) Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort. BJOG: An International Journal of Obstetrics & Gynaecology 123:12, pages 1919-1928.
Crossref
Crossref
Maria Muzik & Susan E. Hamilton. (2016) Use of Antidepressants During Pregnancy?: What to Consider when Weighing Treatment with Antidepressants Against Untreated Depression. Maternal and Child Health Journal 20:11, pages 2268-2279.
Crossref
Crossref
Yanyan Mao, Lars Henning Pedersen, Jakob Christensen, Mogens Vestergaard, Weijin Zhou, Jørn Olsen & Yuelian Sun. (2016) Prenatal exposure to antidepressants and risk of epilepsy in childhood. Pharmacoepidemiology and Drug Safety 25:11, pages 1320-1330.
Crossref
Crossref
Tohru Kobayashi, Tasuku Matsuyama, Masanobu Takeuchi & Shinya Ito. (2016) Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: A systematic review and meta-analysis. Reproductive Toxicology 65, pages 170-178.
Crossref
Crossref
D. Healy, J. Le Noury & D. Mangin. (2016) Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence. International Journal of Risk & Safety in Medicine 28:3, pages 125-141.
Crossref
Crossref
Asher Ornoy, Liza Weinstein- Fudim & Zivanit Ergaz. (2016) Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD). Frontiers in Neuroscience 10.
Crossref
Crossref
Deborah S. BondiOwais A. KhanJoseph Hageman. (2016) Pharmacology Review: Maternal Selective Serotonin Reuptake Inhibitor Use and Neurologic Effects on the Neonate. NeoReviews 17:7, pages e356-e366.
Crossref
Crossref
Roy H. Perlis. (2016) Autism and antidepressant use in pregnancy. The Journal of Pediatrics 174, pages 277-280.
Crossref
Crossref
Maiken I. S. Kjaersgaard & Erik T. Parner. (2016) Instrumental variable method for time-to-event data using a pseudo-observation approach. Biometrics 72:2, pages 463-472.
Crossref
Crossref
Sura Alwan, Jan M. Friedman & Christina Chambers. (2016) Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence. CNS Drugs 30:6, pages 499-515.
Crossref
Crossref
Katharine Baratz Dalke, Amy Wenzel & Deborah R. Kim. (2016) Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making. Current Psychiatry Reports 18:6.
Crossref
Crossref
Heli Malm, Alan S. Brown, Mika Gissler, David Gyllenberg, Susanna Hinkka-Yli-Salomäki, Ian W. McKeague, Myrna Weissman, Priya Wickramaratne, Miia Artama, Jay A. Gingrich & Andre Sourander. (2016) Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study. Journal of the American Academy of Child & Adolescent Psychiatry 55:5, pages 359-366.
Crossref
Crossref
William Mandy & Meng-Chuan Lai. (2016) Annual Research Review: The role of the environment in the developmental psychopathology of autism spectrum condition. Journal of Child Psychology and Psychiatry 57:3, pages 271-292.
Crossref
Crossref
Tina J. Walch & Amanda Tinkelman. (2016) Selective Serotonin Reuptake Inhibitors and Autism. American Journal of Therapeutics 23:2, pages e325.
Crossref
Crossref
Madeleine Becker, Tal Weinberger, Ann Chandy & Sarah Schmukler. (2016) Depression During Pregnancy and Postpartum. Current Psychiatry Reports 18:3.
Crossref
Crossref
Susanne Brummelte & Liisa A.M. Galea. (2016) Postpartum depression: Etiology, treatment and consequences for maternal care. Hormones and Behavior 77, pages 153-166.
Crossref
Crossref
Bengt KällénBengt Källén. 2016. Drugs During Pregnancy. Drugs During Pregnancy
25
36
.
Josephine Power, Megan Galbally & Andrew Lewis. 2016. Pediatric Neurotoxicology. Pediatric Neurotoxicology
107
125
.
Angelika Wieck & Margareta Reis. 2016. Comprehensive Women's Mental Health. Comprehensive Women's Mental Health
122
136
.
. 2016. Comprehensive Women's Mental Health. Comprehensive Women's Mental Health
81
136
.
Faruk Uguz. (2015) Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approach. Revista Brasileira de Psiquiatria 37:4, pages 334-342.
Crossref
Crossref
Lars Henning Pedersen. (2015) Prenatal Antidepressant Exposure and Childhood Autism Spectrum Disorders: Cause for Concern?. Pediatric Drugs 17:6, pages 443-448.
Crossref
Crossref
David E. Ehrlich, Gretchen N. Neigh, Chase H. Bourke, Christina L. Nemeth, Rimi Hazra, Steven J. Ryan, Sydney Rowson, Nesha Jairam, Courtney R. Sholar, Donald G. Rainnie, Zachary N. Stowe & Michael J. Owens. (2015) Prenatal stress, regardless of concurrent escitalopram treatment, alters behavior and amygdala gene expression of adolescent female rats. Neuropharmacology 97, pages 251-258.
Crossref
Crossref
E. R. Larsen, P. Damkier, L. H. Pedersen, J. Fenger-Gron, R. L. Mikkelsen, R. E. Nielsen, V. J. Linde, H. E. D. Knudsen, L. Skaarup & P. Videbech. (2015) Use of psychotropic drugs during pregnancy and breast-feeding. Acta Psychiatrica Scandinavica 132, pages 1-28.
Crossref
Crossref
Shaila MisriJasmin AbizadehShawn SandersElena Swift. (2015) Perinatal Generalized Anxiety Disorder: Assessment and Treatment. Journal of Women's Health 24:9, pages 762-770.
Crossref
Crossref
A. Ornoy, L. Weinstein-Fudim & Z. Ergaz. (2015) Prenatal factors associated with autism spectrum disorder (ASD). Reproductive Toxicology 56, pages 155-169.
Crossref
Crossref
Salvatore Gentile. (2015) Prenatal antidepressant exposure and the risk of autism spectrum disorders in children. Are we looking at the fall of Gods?. Journal of Affective Disorders 182, pages 132-137.
Crossref
Crossref
Teri Pearlstein. (2015) Depression during Pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology 29:5, pages 754-764.
Crossref
Crossref
Gail Erlick Robinson. (2015) Controversies About the Use of Antidepressants in Pregnancy. Journal of Nervous & Mental Disease 203:3, pages 159-163.
Crossref
Crossref
Kenneth K.C. Man, Henry H.Y. Tong, Lisa Y.L. Wong, Esther W. Chan, Emily Simonoff & Ian C.K. Wong. (2015) Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: A systematic review and meta-analysis of observational studies. Neuroscience & Biobehavioral Reviews 49, pages 82-89.
Crossref
Crossref
Katherine L Wisner & Christof Schaefer. 2015. Drugs During Pregnancy and Lactation. Drugs During Pregnancy and Lactation
293
339
.
Christof Schaefer, Valenka Dorsch & Anke Rohde. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
19
.
Nicole B. Gidaya, Brian K. Lee, Igor Burstyn, Michael Yudell, Erik L. Mortensen & Craig J. Newschaffer. (2014) In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder. Journal of Autism and Developmental Disorders 44:10, pages 2558-2567.
Crossref
Crossref
Hanan El Marroun, Tonya White, Frank C. Verhulst & Henning Tiemeier. (2014) Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review. European Child & Adolescent Psychiatry 23:10, pages 973-992.
Crossref
Crossref